<DOC>
	<DOCNO>NCT00475007</DOCNO>
	<brief_summary>This trial men woman age 40 74 confirm diagnosis emphysema . The objective trial determine safety effectiveness IBV Valve redirect airflow diseased portion lung healthy area achieve improvement disease-related health status .</brief_summary>
	<brief_title>Clinical Trial Evaluate Safety Effectiveness IBV® Valve System Treatment Severe Emphysema</brief_title>
	<detailed_description>The IBV Valve Trial multi-center clinical trial evaluate IBV Valve System , non-surgical treatment patient emphysema . The IBV Valve System require traditional surgery surgical incision . The valve place bronchoscopic procedure . The IBV Valve System design redirect airflow diseased portion lung healthy area achieve improvement disease-related health status . Although valve intend permanent , design remove necessary . The IBV Valve Trial randomize , blind trial . This mean participant divide two group know group assign . The IBV Valve Treatment Group receive valve , Control Group . A random selection process decides group assignment ( participant able choose group ) . In trial , everyone 50 percent chance ( similar coin toss ) assign one group . All Participants Clinical Trial : Receive diagnostic bronchoscopy allow expert lung health evaluate lung . Be care highly qualified lung doctor entire time trial , regardless whether Treatment Group Control Group . Receive regular periodic check-ups health assessment throughout 6 month trial period . The procedure , test , doctor visit provide cost participant IBV Valve Treatment Group Control Group . At completion 6-month visit , participant tell assigned Treatment Group Control Group . If participant assign group receive valve ( Control Group ) , give option re-evaluated clinical trial doctor , determine valve treatment .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Candidates mostly upper lobe , severe emphysema . Must able participate standard exercise testing . Willing abstain cigarette smoke 4 month prior entire trial . Willing participate randomize , blind study complete require followup visit study period . Willing participate multiple visit medical center health assessment test . Willing minimum one overnight stay hospital . Evidence another coexist major medical disease . Unable tolerate , flexible bronchoscopy procedure . Active asthma , chronic bronchitis . Diffuse emphysema pattern , alpha 1antitrypsin deficiency . Has prior lung volume reduction surgery .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Emphysema</keyword>
	<keyword>IBV® Valve</keyword>
	<keyword>COPD</keyword>
	<keyword>Shortness Breath</keyword>
	<keyword>Spiration</keyword>
</DOC>